Press release
Global Statins Market size is expected to touch US$ 22 Bn by 2032, advancing at 3.5% CAGR | PMR
Request For Free Sample Report of "Statins Market"@ https://www.persistencemarketresearch.com/samples/3038
The global market for statins is quite large, with billions of dollars in annual sales. The market is driven by the increasing prevalence of cardiovascular disease and other conditions that are linked to high cholesterol levels, such as diabetes and obesity.
Companies
Pfizer Inc.
AstraZeneca plc
Novartis International AG
GlaxoSmithKline plc
Merck & Co., Inc.
Biocon
Aurobindo Pharma Ltd
Concord Biotech
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/3038
There are several different types of statins available, including atorvastatin, rosuvastatin, and simvastatin. These drugs are available in both generic and brand-name form, and are sold by a variety of pharmaceutical companies.
In recent years, there has been controversy surrounding the use of statins, with some people claiming that they have serious side effects, such as muscle pain and weakness, memory loss, and an increased risk of diabetes. However, the overwhelming majority of research suggests that the benefits of statins far outweigh the risks, and that they are a safe and effective treatment for high cholesterol and related conditions.
Market Drivers and Restraints
Rise in the prevalence of cholesterol owing to changing lifestyles has led to increased demand for statins worldwide. There has been a significant rise in patients with obesity, cardiovascular diseases, and diabetes, which, in turn, is expected to drive the demand for statins worldwide.
Furthermore, an increase in healthcare expenditure in emerging regions along with technological advancement, modern healthcare amenities, and various cholesterol-related healthcare campaign is expected to boost overall demand for stains worldwide.
Though the market is poised to grow at a significant rate, increasing preference for alternative medicines in emerging regions is proving a major challenge for the overall growth of the stains market.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/3038
Statins Industry Research Segmentation
By Drug Class:
Astrovastatins
Fluvastatins
Lovastatins
Pravastatins
Simvastatins
Others
By Therapeutic Treatment:
Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others
By End User:
Hospitals
Clinics
For More Premium Insights, Check out the Link:
Endoscopic Spinal Surgery Market - https://www.prnewswire.com/news-releases/endoscopic-spinal-surgery-market-is-expected-to-exhibit-a-cagr-of-over-8-through-the-forecast-period-2021--2031-persistence-market-research-301335524.html
Animal Drug Compounding Market - https://www.prnewswire.com/news-releases/animal-drug-compounding-market-is-set-to-witness-healthy-growth-at-a-cagr-of-8-over-the-forecast-period-of-2021-2031-persistence-market-research-301307646.html
Rheumatoid Arthritis Treatment Market - https://www.prnewswire.com/news-releases/rheumatoid-arthritis-treatment-market-is-expected-to-exhibit-a-cagr-of-around-6-over-the-forecast-period-2021--2031---persistence-market-research-301293405.htmla
Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com
About Us
Persistence Market Research's Expertise in Life Sciences and Transformational Health
Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Statins Market size is expected to touch US$ 22 Bn by 2032, advancing at 3.5% CAGR | PMR here
News-ID: 2916785 • Views: …
More Releases from Persistence Market Research
U.S. CMO/CDMO Market Forecast Highlights Significant CAGR of 8.7% from 2025-2032
The U.S. Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) market is poised for robust expansion, driven by growing demand across pharmaceutical and biopharmaceutical sectors. Valued at approximately US$83.1 billion in 2025, the market is projected to reach US$149.4 billion by 2032, registering a compound annual growth rate (CAGR) of 8.7% during the forecast period. This growth trajectory reflects increased outsourcing of key drug development and manufacturing…
Weaving Machine Market Innovations, Automation, and Emerging Trends Transforming …
The global weaving machine market is experiencing remarkable growth, driven by technological advancements, automation, and the increasing demand for high-quality textiles across industries. Weaving machines, which are essential for producing fabrics ranging from everyday clothing to technical textiles, have evolved significantly from traditional handlooms to fully automated systems.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/32132
The textile industry's focus on efficiency,…
North America Induced Pluripotent Stem Cells Market Growth to Reach US$1,226.7 M …
The North America induced pluripotent stem cells (iPSCs) market is poised for significant expansion, driven by increasing applications in drug development, regenerative medicine, and toxicity testing. Valued at USD 714.3 million in 2025, the market is expected to reach USD 1,226.7 million by 2032, registering a compound annual growth rate (CAGR) of 8.0% during the forecast period. The market's growth is underpinned by rising investment in stem cell research, advancements…
Ophthalmic Devices Market Size to Hit USD 68.51 Billion in 2032, expanding at a …
The ophthalmic devices market plays a vital role in advancing eye care, enhancing diagnostic precision, treatment outcomes, and surgical efficiency. These devices are extensively used in hospitals, specialty clinics, and ambulatory surgical centers for diagnosing and treating conditions such as cataracts, glaucoma, refractive errors, and retinal disorders. They improve patient outcomes by enabling early disease detection, minimally invasive procedures, and accurate vision correction, making them indispensable in modern ophthalmology.
…
More Releases for Statins
Statins Market Size and Forecast
"
Statins Market size was valued at USD 20.5 Billion in 2022 and is projected to reach USD 30.1 Billion by 2030, growing at a CAGR of 5.0% from 2024 to 2030.
Statins Market Outlook and Investment Analysis
What is the current outlook of the Statins Market and its growth prospects?
The statins market is expected to continue its steady growth due to the rising prevalence of cardiovascular diseases, an aging global population, and…
Statins Market to Witness Promising Growth Opportunities by 2021-2031
Global Statins Market Report 2021 is a professional and in-depth survey on the current state of the Statins Industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Statins Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.
Download Sample PDF at
https://www.theinsightpartners.com/sample/TIPRE00011966/?utm_source=OpenPR&utm_medium=10831
Key Players Analysis:
• Amgen
• AstraZeneca
• Aurbindo Pharma
• Biocon
• Concord Biotech
• GlaxoSmithKline plc,
• Merck & Co.,…
The Statins Market To Sail Through Innovation-Based Turbulence
The global Statins Market is bound to witness stupendous growth In Upcoming Years. One of the upcoming trends is that of offbeat thinking being put into practice. Also, the demand regarding automation would rise by over 10% in the subsequent decade. Moreover, with user-generated content creating ripples, the market is bound to blur the gap between one-way communication and constructive feedback to adhere to the end-users mindshare.
Statins are special class…
Statins Market Trends and Forecast to 2026 - TMR
Statins are lipid lowering agents or medications used in the treatment of high lipid levels. These are often referred as high cholesterol found in the blood. The major function of statins is to lower blood cholesterol and prevent atherosclerosis. These drugs help to prevent heart attacks and strokes. These lower the production of cholesterol by blocking an enzyme known as HMG-CoA reductase used by liver. According to studies, statins have…
Statins Market to Reflect a Holistic Expansion During 2016-2022
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients. Demand for statins is long driven by increasing healthcare awareness among common masses. In U.S., over 500,000 people suffers heart attack every year. Though cholesterol level is easy to…
Statins Market to Exhibit Impressive Growth by 2020
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients. Demand for statins is long driven by increasing healthcare awareness among common masses. In U.S., over 500,000 people suffers heart attack every year. Though cholesterol level is easy to…
